title: Changes in plasma hormones and heart rate variability in patients receiving the cardiotoxic anti-cancer agent bevacizumab.
authors.affiliation: Department of Medicine, Queen's University, Kingston, Ontario, Canada; Section of Cardiology, Division of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
authors.forename: William F
authors.initials: WF
authors.lastname: McIntyre
authors.affiliation: Department of Medicine, Queen's University, Kingston, Ontario, Canada; Department of Cardiology, University of Calgary, Calgary, Canada.
authors.forename: Zardasht
authors.initials: Z
authors.lastname: Oqab
authors.affiliation: Department of Medicine, Queen's University, Kingston, Ontario, Canada.
authors.forename: Geoffrey E J
authors.initials: GE
authors.lastname: Seaborn
authors.affiliation: Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
authors.forename: Wilma M
authors.initials: WM
authors.lastname: Hopman
authors.affiliation: Department of Medicine, Queen's University, Kingston, Ontario, Canada.
authors.forename: Nazik
authors.initials: N
authors.lastname: Hammad
authors.affiliation: Department of Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: barancha@kgh.kari.net.
authors.forename: Adrian
authors.initials: A
authors.lastname: Baranchuk
mesh_terms: D000368:Aged; D000450:Aldosterone / Q000097:blood*; D020533:Angiogenesis Inhibitors / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000068258:Bevacizumab / Q000009:adverse effects*; D054715:Cardiotoxins / Q000009:adverse effects*; D015179:Colorectal Neoplasms / Q000097:blood* / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006339:Heart Rate / Q000187:drug effects* / Q000502:physiology; D006728:Hormones / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D054715:Cardiotoxins; D006728:Hormones; D000068258:Bevacizumab; D000450:Aldosterone
keywords: Autonomic nervous system; Cardio-oncology; Heart rate variability; Hypertension; Vascular endothelial growth factor